Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

Published:2018-08 Issue:2 Volume:155 Page:337-346.e10
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Kirchgesner Julien^ORCID,Lemaitre Magali^ORCID,Carrat Fabrice,Zureik Mahmoud,Carbonnel Franck,Dray-Spira Rosemary^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. Infliximab, azathioprine, or combination therapy for Crohn’s disease;Colombel;N Engl J Med,2010

2. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis;Panaccione;Gastroenterology,2014

3. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 2: surgical management and special situations;Gionchetti;J Crohns Colitis,2016

4. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management;Harbord;J Crohns Colitis,2017

5. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease;Rahier;J Crohns Colitis,2014

Cited by 448 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study;eBioMedicine;2024-10

2. 6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy;Internal Medicine Journal;2024-09-05

3. Co-administration of 1,25-dihydroxyvitamin D3 and infliximab improves colitis in mice by modulating Treg differentiation;IRAN J BASIC MED SCI;2024

4. A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-08-27

5. Epithelial barrier dysfunction and microbial dysbiosis: exploring the pathogenesis and therapeutic strategies for Crohn’s disease;Tissue Barriers;2024-08-26